verzenios
eli lilly nederland b.v. - abemaciclib - neoplazme dojke - antineoplastična sredstva - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.
ngenla
pfizer europe ma eeig - somatrogon - growth and development - hipofiza in hypothalamic hormoni in analogi - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.
sevelamer lek 800 mg filmsko obložene tablete
lek d.d. - sevelamer - filmsko obložena tableta - sevelamer 800 mg / 1 tableta - sevelamer
hidrokortizon altamedics 10 mg tablete
altamedics d.o.o. - hidrokortizon - tableta - hidrokortizon 10 mg / 1 tableta - hidrokortizon
novtirox 100 mikrogramov tablete
aspen pharma trading limited - natrijev levotiroksinat - tableta - natrijev levotiroksinat 100 mg / 1 tableta - natrijev levotiroksinat
exubera
pfizer limited - insulin human - sladkorna bolezen - zdravila, ki se uporabljajo pri diabetesu - exubera je indiciran za zdravljenje odraslih bolnikov z diabetesom tipa 2, bolezni notadequately nadzira z ustno antidiabetic sredstva in potrebujejo insulin terapija. exubera je prikazano tudi za zdravljenje odraslih bolnikih s tipom 1 sladkorne bolezni, inaddition za dolgo ali vmesne deluje podkožnega insulina, za katere potencialne koristi ofadding pri vdihavanju insulina odtehtajo morebitne pomisleke glede varnosti (glej poglavje 4.
fulvestrant mylan
mylan pharmaceuticals limited - fulvestrant - neoplazme dojke - endokrini terapija - fulvestrant je primerna za zdravljenje estrogen receptor pozitivno, lokalno napredno ali metastatskega raka dojke pri ženskah po menopavzi:ne prej, zdravljenih z endokrinih terapije, orwith ponovitve bolezni na ali po adjuvant anti-estrogen terapije, ali napredovanja bolezni na antiestrogen terapija.
ghryvelin (previously macimorelin aeterna zentaris)
atnahs pharma netherlands b.v. - macimorelin acetat - diagnostične tehnike, endokrine - macimorelin - to zdravilo je samo za diagnostično uporabo. ghryvelin is indicated for the diagnosis of growth hormone deficiency (ghd) in adults.
efmody
diurnal europe b.v. - hidrokortizon - adrenal hyperplasia, congenital - kortikosteroidi za sistemsko uporabo - treatment of congenital adrenal hyperplasia (cah) in adolescents aged 12 years and over and adults.
climara 50 mikrogramov/24 ur transdermalni obliž
bayer d.o.o. - estradiol - transdermalni obliž - estradiol 3,8 mg / 1 obliž - estradiol